Humacyte (HUMA) stock: insider trades, news & valuation
Health Care · Net buyingShare price and insider trades
Humacyte insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $68K and 2 sold $83K of HUMA stock on the open market.
Get emailed when insiders cluster-buy stocks like HUMA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
HUMA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $30K | 3 | — | 0 |
| Q2 2026 | $60K | 2 | $83K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Humacyte, Inc. insiders reported open-market purchases totaling $68K, while 2 insiders reported sales totaling $83K. 2 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Members of Congress who traded HUMA
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Thomas H TubervilleSenate | Sold $1,001 - $15,000 | May 3, 2024 | Aug 5, 2026 | -92.8% |
| Thomas H TubervilleSenate | Sold $15,001 - $50,000 | May 3, 2024 | Aug 5, 2026 | -92.8% |
| Thomas H TubervilleSenate | Bought $1,001 - $15,000 | Mar 21, 2024 | Aug 5, 2026 | -92.8% |
| Thomas H TubervilleSenate | Bought $1,001 - $15,000 | Mar 21, 2024 | Aug 5, 2026 | -92.8% |
| Thomas H TubervilleSenate | Bought $15,001 - $50,000 | Mar 21, 2024 | Aug 5, 2026 | -92.8% |
HUMA stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 15SEC | Keith Anthony JonesDirector | Buy | 10,00050,000 held (+25%) | $0.56 | $6K | -27.7% | — |
| Aug 21SEC | Keith Anthony JonesDirector | Buy | 10,00040,000 held (+33%) | $0.69 | $7K | -41.3% | — |
| Aug 19SEC | Keith Anthony JonesDirector | Buy | 30,000new position | $0.59 | $18K | -31.4% | — |
| May 20SEC | Kathleen SebeliusDirector | Buy | 56,818148,025 held (+62%) | $0.88 | $50K | -54.0% | — |
| May 20SEC | Shamik J ParikhChief Medical Officer | Sell Plan | 45,887272,713 held (−14%) | $0.90 | $41K | -55.0% | — |
| May 20SEC | Dale A. SanderCFO | Sell Plan | 45,887267,213 held (−15%) | $0.90 | $41K | -55.0% | — |
| May 20SEC | Michael T. ConstantinoDirector | Buy | 11,00043,950 held (+33%) | $0.89 | $10K | -54.5% | — |
Insiders at Humacyte, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Kathleen SebeliusDirector | $50K | — | May 20, 2026 | — |
| Keith Anthony JonesDirector | $30K | — | Sep 15, 2026 | — |
| Shamik J ParikhChief Medical Officer | — | $41K | May 20, 2026 | — |
| Dale A. SanderCFO | — | $41K | May 20, 2026 | — |
| Michael T. ConstantinoDirector | $10K | — | May 20, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
HUMA stock: common questions
Are Humacyte, Inc. insiders buying HUMA stock?
In the past 12 months, 2 insiders reported open-market purchases of HUMA worth $68K. The latest was Director Keith Anthony Jones bought $6K of HUMA at $0.56 — raises the stake by 25%.
Are Humacyte, Inc. insiders selling HUMA stock?
2 insiders reported sales worth $83K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is HUMA's 52-week range?
Over the past year HUMA has traded between $0.41 and $1.81. It last closed at $0.41 on Oct 9, 2026.